View older revisions Content changed at 2025-05-05, 1404/02/15

Protocol summary

Study aim
Evaluation and comparison of clinical pregnancy rate in two methods of endometrial preparation using hormone administration method and natural modified method in frozen embryo transfer cycle.
Design
The current study is clinical and prospective. Patients are randomly assigned to two endometrial preparation groups. Basic ultrasound is performed for 128 patients on day 2 of the cycle and they are planned to be placed in each of the endometrial preparation protocols.
Settings and conduct
This study is conducted in Imam Khomeini Hospital in Sari Patients in the modified normal cycle group undergo an ultrasound scan on day 10 to 12 of the menstrual cycle to determine the size of the dominant follicle. And when a follicle equal to or greater than 18 mm is seen, ovulation is induced by Ovitrelle injection, and progesterone begins three days later of Ovitrelle injection . will be For patients in the hormone administration cycle group treated with estradiol valerate, ultrasound is performed starting from the 2nd day of menstruation and approximately 10 days after the start of estradiol treatment, when the thickness of the endometrium reaches 8 mm, progesterone will start.
Participants/Inclusion and exclusion criteria
Inclusion criteria : Age 20-40 years with monthly menstrual cycles; Normal BMI (18-30 kg/m2) ; At the time of embryo transfer, at least one or two good-quality embryos; Patients with first or second transfusion Exit criteria: Women with uterine anatomic abnormalities, hydrosalpinx, endometriosis. ovulation disorders. needed preimplantation genetic testing. recurrent miscarriages and recurrent implantation failure. medical conditions who were interdicted ART/pregnancy
Intervention groups
Two groups of frozen embryo transfer with endometrium preparation protocol with hormone administration method and natural modified method
Main outcome variables
Clinical pregnancy

General information

Reason for update
The study's sampling and completion were completed later than the announced time, and the realized volume was greater than the determined sample size. In addition, more outcomes were examined.
Acronym
IRCT registration information
IRCT registration number: IRCT20240302061147N1
Registration date: 2024-05-27, 1403/03/07
Registration timing: registered_while_recruiting

Last update: 2025-05-05, 1404/02/15
Update count: 3
Registration date
2024-05-27, 1403/03/07
Registrant information
Name
Farnaz Safarloo
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 912 508 3244
Email address
safarloo203@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-04-20, 1403/02/01
Expected recruitment end date
2024-07-22, 1403/05/01
Actual recruitment start date
2024-04-29, 1403/02/10
Actual recruitment end date
2024-08-07, 1403/05/17
Trial completion date
2024-10-21, 1403/07/30
Scientific title
Evaluation and comparison of clinical pregnancy rate in two methods of endometrial preparation using hormone therapy method and modified natural cycle of in frozen embryo transfer cycle.
Public title
Evaluation and comparison of clinical pregnancy rate in two methods of endometrial preparation using hormone therapy method and modified natural cycle of in frozen embryo transfer cycle.
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age 20-40 years with monthly menstrual cycles of 21 to 35 days Normal BMI (18-30 kg/m2) At the time of embryo transfer, there should be at least one or two embryos with good-quality Patients with first or second transfer
Exclusion criteria:
Women who were diagnosed with uterine anatomic abnormalities, either inborn or acquired, hydrosalpinx, and endometriosis. The patients with ovulation disorders. Women who needed preimplantation genetic testing. Women who suffered from recurrent miscarriages and recurrent implantation failure. Women with medical conditions who were interdicted ART/pregnancy.
Age
From 20 years old to 40 years old
Gender
Female
Phase
N/A
Groups that have been masked
  • Investigator
  • Data analyser
Sample size
Target sample size: 100
More than 1 sample in each individual
Number of samples in each individual: 50
50 people per group
Actual sample size reached: 128
More than 1 sample in each individual
Actual sample size in each individual: 64
64 people per group
Randomization (investigator's opinion)
Randomized
Randomization description
Infertile patients who refer to Imam Hospital in Sari city, after obtaining their consent, are randomly assigned in a one-to-one ratio and enter one of the two endometrial preparation groups. Blocking is done in each group based on age (less than 35 years old and 35 to 40 years old).
Blinding (investigator's opinion)
Single blinded
Blinding description
The present study is a single-blind RCT in which the embryologist and data assessor were blind to treatment groups. Therefore, patients were not blinded to comply with ethical issues and gave the patient the right to choose. Moreover, double blinding was not possible due to the intervention method. The doctor and the patient were aware of the intervention procedure.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Mazandaran University of Medical Sciences
Street address
Infertility Department,Imam Khomeini hospital, razi street, Sari city, Mazandaran province, Iran
City
sari
Province
Mazandaran
Postal code
4816633131
Approval date
2024-01-15, 1402/10/25
Ethics committee reference number
ir.mazums.imamhospital.rec.1402.125

Health conditions studied

1

Description of health condition studied
Frozen embryo transfer in modified natural cycle
ICD-10 code
N97.4
ICD-10 code description
Evaluation and comparison of clinical pregnancy rate in two methods of endometrial preparation using hormone therapy method and modified natural cycle of in frozen embryo transfer cycle

Primary outcomes

1

Description
Clinical pregnancy so that the heartbeat of the fetus can be seen in ultrasound
Timepoint
5 weeks after embryo transfer or 8th week of pregnancy
Method of measurement
By transvaginal ultrasound

Secondary outcomes

1

Description
The rate of chemical pregnancy in which only the pregnancy test is positive (B-hCG> 50 IU/l), but no clinical pregnancy was confirmed on vaginal ultrasound in the 8th week.
Timepoint
the 8th week of pregnancy
Method of measurement
Laboratory test and transvaginal ultrasound

2

Description
Miscarriage rate (loss of clinical pregnancy before the 12th gestational week)
Timepoint
before the 12th gestational week
Method of measurement
Trans vaginal ultrasound

3

Description
implantation rate (IR was defined as the number of gestational sacs determined by sonogram divided by the number of frozen embryos transferred )
Timepoint
6th gestational week
Method of measurement
transvaginal ultrasound

4

Description
ectopic pregnancy rate (EPR) (refers to the presence of a gestational sac outside the uterine cavity)
Timepoint
6 to 7th gestational week
Method of measurement
Laboratory test and transvaginal ultrasound

5

Description
twin pregnancy rate (TPR)
Timepoint
the 8th week of pregnancy
Method of measurement
transvaginal ultrasound

6

Description
ongoing pregnancy (Ongoing pregnancy was defined as a continuation of pregnancy after the 12th week of gestation).
Timepoint
after the 12th week of gestation
Method of measurement
Abdominal ultrasound

7

Description
rates of positive hCG,( positive hCG was defined as B-hCG > 50 IU/l measured 14 days after transfer)
Timepoint
14 days after embryo transfer
Method of measurement
Laboratory test

8

Description
cycle cancelation: in mnc If there were no dominant follicles (follicle diameter ≥ 16 mm) until the 16th day, the cycle was canceled. In hrc, the cycle was canceled if the endometrial thickness was still insufficient after 18 days of estrogen administration.
Timepoint
in mnc 16th day cycle and 18th day cycle in hrc
Method of measurement
transvaginal ultrasound

9

Description
Number of visit(Number of visits from the start of the cycle to embryo transfer)
Timepoint
from the start of the cycle to embryo transfer
Method of measurement
According to the patient's file

Intervention groups

1

Description
Intervention group: Patients in the modified normal cycle (mNC-FET) group underwent transvaginal ultrasound on day 10 to 12 of the menstrual cycle to determine the size of the dominant follicle and thus the ovulation induction time. If the ovulation induction time is not determined on the 12th day, the transvaginal ultrasound is repeated 2 days later. And when a follicle equal to or greater than 18 mm is seen, ovulation is induced by injecting 250 micrograms of r-hCG (6500 IU Ovitrelle). Embryo transfer will be done 5-6 days after ovulation induction, and they will receive 800 mg of micronized progesterone daily for four to five days until the time of embryo transfer, and based on the condition of the frozen embryo, 24-48 hours before the time set for Transfer will melt.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Imam Khomeini Hospital, Sari
Full name of responsible person
Dr. Sepideh Peivandi
Street address
Amir Mazandarani Street
City
Sari
Province
Mazandaran
Postal code
4816633131
Phone
+98 11 3336 1700
Fax
+98 11 3336 3754
Email
emamsarih@gmail.com
Web page address

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Mazandaran University of Medical Sciences
Full name of responsible person
Dr.Farhad Gholami
Street address
The beginning of Valiasr Highway, Joibar Three Roads, Imam Khomeini Square
City
Sari
Province
Mazandaran
Postal code
4815733971
Phone
+98 11 3304 4000
Email
ravabetomoomi@mazums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mazandaran University of Medical Sciences
Proportion provided by this source
10
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Mazandaran University of Medical Sciences
Full name of responsible person
Farnaz Safarlou
Position
Fellowship Assistant
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Infertility Center of Imam Khomeini Hospital, Razi Street
City
Sari
Province
Mazandaran
Postal code
4816633131
Phone
+98 11 3336 1700
Email
Safarloo203@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Mazandaran University of Medical Sciences
Full name of responsible person
Farnaz Safarlou
Position
Fellowship Assistant
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Infertility Center of Imam Khomeini Hospital, Razi Street
City
Sari
Province
Mazandaran
Postal code
4816633131
Phone
+98 11 3336 1700
Email
Safarloo203@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Mazandaran University of Medical Sciences
Full name of responsible person
Farnaz Safarloo
Position
Fellowship Assistant
Latest degree
Specialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Infertility Center, Imam Khomeini Hospital, Razi Street
City
Sari
Province
Mazandaran
Postal code
4816633131
Phone
+98 11 3336 1700
Email
Safarloo203@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
The design protocol, demographic information of the patients, and statistical results will be published as an article after the end of the study
When the data will become available and for how long
After publication in one of the authoritative publications
To whom data/document is available
Academic centers and infertility researchers
Under which criteria data/document could be used
Research exploitation
From where data/document is obtainable
Email of researchers and Mazandaran University of Medical Sciences
What processes are involved for a request to access data/document
About six months after the end of the study
Comments
Loading...